GLP-1 drugs , or glucagon-like peptide-1 receptor agonists , represent a substantial shift in how we handle high blood sugar. These new drugs help mimicking the body’s natural GLP-1 process, which https://bookmarkport.com/story24536202/glp-1-a-major-approach-in-glucose-treatment